Octacillin 697 mg/g Powder for use in drinking water for Chickens

Main information

  • Trade name:
  • Octacillin 697 mg/g Powder for use in drinking water for Chickens
  • Pharmaceutical form:
  • Powder and solvent for oral solution
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Octacillin 697 mg/g Powder for use in drinking water for Chickens
    Greece
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • Penicillins with extended spectrum
  • Therapeutic area:
  • Chicken Non Food

Other information

Status

  • Source:
  • HMA - Europe
  • Authorization number:
  • UK/V/0214/001
  • Authorization date:
  • 02-09-2011
  • EU code:
  • UK/V/0214/001
  • Last update:
  • 09-08-2016

Summary of Product characteristics: dosage,interactions,side effects

Revised:July2011

An:00487/2010

SUMMARYOFPRODUCTCHARACTERISTICS

1 NAMEOFTHEVETERINARYMEDICINALPRODUCT

Octacillin697mg/gpowderforuseindrinkingwaterforchickens

2 QUALITATIVEANDQUANTITATIVECOMPOSITION

Activesubstance:

Amoxicillin(asAmoxicillintrihydratePh.Eur.) 697mg/g

Forafulllistofexcipients,seesection6.1

3 PHARMACEUTICALFORM

Powderforuseindrinkingwater

Whitetopaleyellow-whitepowder

4 CLINICALPARTICULARS

4.1 Targetspecies

Chickens(excludinglayingbirdsproducingeggsforhumanconsumption).

4.2 Indicationsforuse,specifyingthetargetspecies

Treatmentofinfectionsinchickenscausedbybacteriasusceptibletoamoxicillin.

Noteffectiveagainstbeta-lactamaseproducingorganisms.

4.3 Contra-indications

Donotuseinknowncasesofhypersensitivitytopenicillinorothersubstancesofthebeta-

lactamgroup.

Donotuseinrabbits,guineapigs,hamsters,gerbilsoranyothersmallherbivores.

4.4 Specialwarningforeachtargetspecies.

None.

4.5 Specialprecautionsforuse

Specialprecautionsforuseinanimals

Useoftheproductshouldbebasedonsusceptibilitytestinganditshouldtakeintoaccount

officialandlocalantimicrobialpolicies.

Inappropriateuseoftheproductmayincreasetheprevalenceofbacteriaresistanceto

amoxicillineandmaydecreaseitseffectiveness.

Revised:July2011

An:00487/2010

Specialprecautionstobetakenbythepersonadministeringtheveterinary

medicinalproducttoanimals

Penicillinsandcephalosporinsmaycausehypersensitivity(allergy)followinginjection,

inhalation,ingestionorskincontact.Hypersensitivitytopenicillinsmaycausecross

reactionstocephalosporinsandviceversa.Allergicreactionstothesesubstancesmay

occasionallybeserious.

1. Peoplewithknownhypersensitivitytopenicillinorcephalosporinshouldavoidcontact

withtheproduct.

2. Handlethisproductwithgreatcaretoavoidexposure,takingallrecommended

precautions.Wearprotectiveclothing,imperviousglovesandeitheradisposablehalf

maskrespiratorconformingtoEuropeanStandardEN149oranon-disposable

respiratorconformingtoEuropeanStandardEN140withafiltertoEN143when

mixingandhandlingtheproduct.Washhandsafteruse.

3. Ifyoudevelopsymptomsfollowingexposure,suchasaskinrash,youshouldseek

medicaladviceandshowthedoctorthiswarning.Swellingoftheface,lipsoreyesor

difficultywithbreathingaremoreserioussymptomsandrequireurgentmedical

attention.

4.6 Adversereactions(frequencyandseriousness)

Hypersensitivityreactionsmayoccur.

4.7 Useduringpregnancy,lactationorlay

Donotuseinbirdsinlayproducingeggsforhumanconsumption.Useinbreedersonly

accordingtothebenefit/riskassessmentbytheresponsibleveterinarian

4.8 Interactionwithothermedicinalproductsandotherformsofinteraction

Amoxicillinexertsitsbactericidalactionbyinhibitionofbacterialcellwallsynthesisduring

multiplication.Itisthereforeinprinciplenotcompatiblewithbacteriostaticantibiotics(e.g.

tetracyclines)whichinhibitmultiplication.Synergismoccurswithß-lactamantibioticsand

aminoglycosides.

Revised:July2011

An:00487/2010

4.9 Amountstobeadministeredandadministrationroute

Therecommendeddosageis10-20mgoftheproductperkgliveweight(8-16mg/kg

amoxicillintrihydrate)perdayadministeredinthedrinkingwater.Thehigherdoseis

advisedwhentreatingsevereinfections.Treatmentshouldbegivenforaperiodof3-5

consecutivedays.Thefollowingformulamaybeusedtocalculatetheamountofproduct

requiredperday:

gramproductperday=numberofbirdsxaverageliveweight(kg)

50(for20mg/kg)or100(for10mg/kg)

Iftherequiredamountofproductiscalculatedbythetotaldailywaterintake,thefollowing

isaguide:

Birds0-4weeksofage: 6-12gproduct/100litreswateruptake/day

Birdsolderthan4weeks: 10-20gproduct/100litreswateruptake/day

Itisrecommendedthattheproductbeadministeredoncedailyinthedrinkingwater.Itis

advisabletorestrictdrinkingwaterforapproximately2hours(lessinhotweather)priorto

medication.Theuseofsuitablycalibratedweighingequipmentfortheadministrationofthe

calculatedamountofproductisrecommended.Thecalculatedtotaldailyamountof

powderisscatteredontothesurfaceof5-10litresofcleanwaterandstirreduntilevenly

dispersed.Thissolutionisthenadded,whilststirring,intoanamountofdrinkingwaterthat

willbeconsumedwithinapproximately2hours.Maximumsolubilityoftheproductinwater

isapproximately6g/litre.

If,however,continuousmedicationispreferredthenthedrinkingwatershouldbe

refreshedwithmedicatedwateratleasttwicedaily.Inallcasesensurethatthereisno

accesstounmedicatedwaterwhilstmedicatedwaterisbeingoffered.Whenallmedicated

waterhasbeenconsumed,turnonthenormalwatersupplyagain.Anyunusedmedicated

watershouldbediscardedafter12hours.

Toensureacorrectdosagebodyweightshouldbedeterminedasaccuratelyaspossible

toavoidunderdosing.Theuptakeofmedicatedwaterdependsontheclinicalconditionof

theanimals.Inordertoobtainthecorrectdosagetheconcentrationofamoxicillinhastobe

adjustedaccordingly.

4.10Overdose(symptoms,emergencyprocedures,antidotes)

Noneknown.

4.11Withdrawalperiods

Meatandoffal:1day

Eggs:Notauthorisedforuseinlayingbirdsproducingeggsforhumanconsumption.

5 PHARMACOLOGICALPROPERTIES

Pharmacotherapeuticgroup:Beta-lactamantibacterial,Penicillin

ATCvetcode:QJ01CA04

Revised:July2011

An:00487/2010

5.1. Pharmacodynamicproperties

Theactiveingredient,amoxicillin,isabactericidalantibioticofthebeta-lactamclass.It

actsbyinhibitionofbacterialcellwallsynthesis.Amoxicillinisnotresistanttotheactionof

beta-lactamases,whichcanhydrolysethemoleculescausingthebeta-lactamring

structuretoopen,renderingitantibioticallyinactive.

Theinformationforstaphylococcalbeta-lactamaseisencodedinaplasmidandmaybe

transferredbybacteriophagetootherbacteria.InG-bacteriabeta-lactamasesare

encodedineitherchromosomesorinplasmidsandtheymaybeconstitutiveorinducible.

Plasmidsmaybetransferredbetweenbacteriathroughconjugation.

Somebacteriaareintrinsicallyresistanttoamoxicillin,becausetheyhavedecreased

affinityfortheantibiotic.Decreasedaffinitymayalsobeacquiredbyhomologous

recombinationbetweengenesofdifferentspecies.Otherinstancesofbacterialresistance

arecausedbytheinabilityoftheagenttopenetratetoitssiteofaction(someG-bacteria)

orbyenergydependenteffluxsystemsforpumpingtheantibioticoutofthebacteria.

Ingeneral,practicaldevelopmentofresistanceinvitroagainstamoxicillinlikeallpenicillins

occursslowlyandstepwise,withanexistingcross-resistancewithotherpenicillinswhichis

ofpracticalsignificancebystaphylococci.

Bothlongtermtreatmentandsub-therapeuticdosagescanselectforantimicrobial

resistance.AmoxicillinisgenerallyactiveagainstsomeGram-negativeandmostGram-

positivebacteriae.g.penicillinsensitiveStaphylococci,Streptococci,Pasteurellaspp.,

Clostridiumspp.,Salmonellaspp.,Haemophilusparagallinarum,andE.coli.Resistance

amongstE.colistrainsisnotuncommon.

5.2 Pharmacokineticproperties

Followingoralmedicationamoxicillinisrapidlyabsorbed.Maximumamoxicillin

concentrations(between1-2µg/ml)arereachedwithin1-2hours.Serumproteinbindingis

low.Amoxicilliniswidelydistributedthroughoutthebody.Amoxicillinismainlyeliminated

viathekidneysintheactiveform.Asmallerpartoftheadministereddoseofamoxicillinis

excretedinthebile.Plasmahalf-lifetimeofamoxicillininchickensisapproximately1hour.

6. PHARMACEUTICALPARTICULARS

6.1 Listofexcipients

Sodiumcarbonatemonohydrate

Sodiumcitrate

Silicacolloidalanhydrous

6.2 Incompatibilities

Intheabsenceofcompatibilitystudies,thisveterinarymedicinalproductmustnotbe

mixedwithotherveterinarymedicinalproducts.

6.3 Shelflife

-Shelf-lifeoftheveterinarymedicinalproductaspackagedforsale:2years

-Shelf-lifeafterfirstopeningtheimmediatepackaging:3months

-Shelf-lifeafterdilutionorreconstitutionaccordingtodirections:12hours

Revised:July2011

An:00487/2010

6.4 Storageprecautions

Thisveterinarymedicinalproductdoesnotrequireanyspecialstorageconditionspriorto

opening.Afteropening,anyremainingcontentcanbestoredfor3monthsifstoreddryand

re-closedwithclip(afterfoldingtheedgeoftheopenedsachet).Asmetaltanksmay

negativelyinfluencestabilityoftheproduct,metaltanksshouldnotbeusedforstorageof

solutions.

6.5 Natureandcompositionofimmediatepackaging

Theprimarypackagingmaterialoftheproductcomprisesaluminiumsachetsof100,250,

500and1000gram.Notallpacksizesmaybemarketed.

Thesachetsconsistofthefollowingmaterials:ontheoutsideawhitelayer,insidedifferent

transparentlayers,asub-layerofaluminiumandaninnerlayerofpolyethylene.

6.6 Specialprecautionsforthedisposalofunusedveterinarymedicinalproduct

orwastematerialsderivedfromtheuseofsuchproducts

Anyunusedveterinarymedicinalproductorwastematerialsderivedfromsuchveterinary

medicinalproductshouldbedisposedofinaccordancewithlocalrequirements.

7. MARKETINGAUTHORISATIONHOLDER

EurovetAnimalHealthB.V.

Handelsweg25

5531AEBladel

TheNetherlands

8. MARKETINGAUTHORISATIONNUMBER

Vm16849/4004

9. DATEOFFIRSTAUTHORISATION

6September2004

10 DATEOFREVISIONOFTHETEXT

July2011

31-10-2018

Safety and efficacy of a super critical carbon dioxide extract of Humulus lupulus L. flos when used as a feed flavouring for all animal species

Safety and efficacy of a super critical carbon dioxide extract of Humulus lupulus L. flos when used as a feed flavouring for all animal species

Published on: Tue, 30 Oct 2018 00:00:00 +0100 Following a request from the European Commission, the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of a super critical carbon dioxide extract of Humulus lupulus L. flos (hop strobiles) when used as a sensory feed additive for all animal species. The additive is specified to containing 40% beta acids and less than 0.2% alpha acids. Known substances of conce...

Europe - EFSA - European Food Safety Authority Publications

There are no news related to this product.